Recent Advances in Models, Mechanisms, Biomarkers, and Interventions in Cisplatin-Induced Acute Kidney Injury

Por Holditch, Sara J., Brown, Carolyn N., Lombardi, Andrew M., Nguyen, Khoa N., Edelstein, Charles L.
Publicado no Int J Mol Sci (2019)

A study of sirolimus and mTOR kinase inhibitor in a hypomorphic Pkd1 mouse model of autosomal dominant polycystic kidney disease

Por Holditch, Sara J., Brown, Carolyn N., Atwood, Daniel J., Lombardi, Andrew M., Nguyen, Khoa N., Toll, Harrison W., Hopp, Katharina, Edelstein, Charles L.
Publicado no Am J Physiol Renal Physiol (2019)

IL-33 deficiency slows cancer growth but does not protect against cisplatin-induced AKI in mice with cancer

Por Ravichandran, Kameswaran, Holditch, Sara, Brown, Carolyn N., Wang, Qian, Ozkok, Abdullah, Weiser-Evans, Mary C., Nemenoff, Raphael, Miyazaki, Makoto, Thiessen-Philbrook, Heather, Parikh, Chirag R., Ljubanovic, Danica, Edelstein, Charles L.
Publicado no Am J Physiol Renal Physiol (2018)

The effect of MEK1/2 inhibitors on cisplatin-induced acute kidney injury (AKI) and cancer growth in mice

Por Brown, Carolyn N., Atwood, Daniel J., Pokhrel, Deepak, Ravichandran, Kameswaran, Holditch, Sara J., Saxena, Sanskriti, Miyazaki, Makoto, Nemenoff, Raphael, Weiser-Evans, Mary C.M., Ljubanovic, Danica Galesic, Joy, Melanie S., Edelstein, Charles L.
Publicado no Cell Signal (2020)

Metabolomics assessment reveals oxidative stress and altered energy production in the heart after ischemic acute kidney injury in mice

Por Fox, Benjamin M, Gil, Hyo-Wook, Kirkbride-Romeo, Lara, Bagchi, Rushita A., Wennersten, Sara A., Haefner, Korey R., Skrypnyk, Nataliya I, Brown, Carolyn N, Soranno, Danielle E., Gist, Katja, Griffin, Benjamin, Jovanovich, Anna, Reisz, Julie A, Wither, Matthew J, D’Alessandro, Angelo, Edelstein, Charles L, Clendenen, Nathan, McKinsey, Timothy, Altmann, Christopher, Faubel, Sarah
Publicado no Kidney Int (2019)